Eyecare Omk1®
DÁVI Produto Eyecare Omk1®

Composition

Citicoline monosodium salt, hyaluronic acid, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate dodecahydrate, sodium chloride, benzalkonium chloride, water for injections.

Sterile ophthalmic solution

Description

Due to the presence of citicoline and its structural action on retinal ganglion cells, EYECARE OMK1® is indicated as an adjunctive treatment for patients with glaucoma receiving ocular hypotensive therapy.

In addition, the moisturising and protective properties of the product provide ocular relief in cases of irritation, burning sensation and foreign body sensation caused by environmental factors, ocular surgery or conjunctivitis.

Medical device

Morada da Sede
Rua Alto do Montijo
13 ED Monsanto
2790-012 Carnaxide, Portugal
Telefone
+351 211 348 501
(Chamada para rede fixa nacional)
Email e candidaturas
geral@davi.pt
DAVI II – FARMACÊUTICA, S.A.
Estrada Consiglieri Pedroso, 69 B – Queluz de Baixo – 2730-055 Barcarena,
Sociedade Anónima – Matriculada na Conservatória do Registo Comercial de Cascais, sob o nº 508 309 450 Capital Social 217.203,00€
Nº de contribuinte 508 309 450
DÁVI II - FARMACÊUTICA, S.A. – All rights reserved – Privacy Policy – by